The novel capsazepine analog, CIDD‐99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1‐independent induction of ER stress, mitochondrial dysfunction, and apoptosis
De La Chapa, Jorge J., Singha, Prajjal K., Self, Kristen K., Sallaway, McKay L., McHardy, Stanton F., Hart, Matthew J., McGuff, Howard Stan, Valdez, Matthew C., Ruiz, Francisco, Polusani, Srikanth R., Gonzales, Cara B.
Published in Journal of oral pathology & medicine (01.05.2019)
Published in Journal of oral pathology & medicine (01.05.2019)
Get full text
Journal Article
Clinical significance of kallikrein-related peptidase-4 in oral cancer
Papagerakis, Petros, Pannone, Giuseppe, Zheng, L I, Athanassiou-Papaefthymiou, Maria, Yamakoshi, Yashuo, McGuff, Howard Stan, Shkeir, Omar, Ghirtis, Konstantinos, Papagerakis, Silvana
Published in Anticancer research (01.04.2015)
Get full text
Published in Anticancer research (01.04.2015)
Journal Article
The novel capsazepine analog, CIDD ‐99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV 1‐independent induction of ER stress, mitochondrial dysfunction, and apoptosis
De La Chapa, Jorge J., Singha, Prajjal K., Self, Kristen K., Sallaway, McKay L., McHardy, Stanton F., Hart, Matthew J., McGuff, Howard Stan, Valdez, Matthew C., Ruiz, Francisco, Polusani, Srikanth R., Gonzales, Cara B.
Published in Journal of oral pathology & medicine (01.05.2019)
Published in Journal of oral pathology & medicine (01.05.2019)
Get full text
Journal Article